Last reviewed · How we verify
NCT06189131: LESS
The Use of Ventriject to Assess V02Max in Patients Admitted to Hospital in the Emergency Surgery Setting
NA trial testing Ventriject in Emergencies in 68 participants. Suspended.
11 November 2025
Quick facts
| Lead sponsor | The Leeds Teaching Hospitals NHS Trust |
|---|---|
| Phase | NA |
| Status | Suspended |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 68 |
| Start date | 3 November 2023 |
| Primary completion | 11 November 2025 |
| Estimated completion | 11 November 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Ventriject
Conditions studied
- Emergencies — all drugs for Emergencies →
- Surgery — all drugs for Surgery →
Sponsor
The Leeds Teaching Hospitals NHS Trust
Who can join
18 and older, any sex, with Emergencies or Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to assess whether Ventriject V02Max can provide values in a clinical setting and whether this value correlates with clinical outcome in patients admitted to the emergency general surgery department in a single centre. We will also be assessing the acceptability of the device to patients and clinicians.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06189131
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emergencies
Currently open trials in the same condition.
- NCT06565390 — Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization · NA · recruiting
- NCT07051668 — The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls · NA · recruiting
- NCT06680778 — Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch · recruiting
- NCT07008391 — High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS · NA · recruiting
- NCT07027813 — Feasibility and Efficacy of Ambulance-Based m-Health for Pediatric Emergencies (FEAMER) Trial · NA · recruiting
Other The Leeds Teaching Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT06728956 — Assessing NHS ImplemeNTation of an onlinE Resilience Training Acceptance and Commitment Therapy (ACT) Programme to Preve · NA · recruiting
- NCT06533917 — Spinal Cord Stimulation for Chronic Abdominal Pain Patients · NA · recruiting
- NCT06110845 — CLinical Evaluation Of a comPuter Algorithm To Report BreAst cAncers (CLEOPATRAA) · not yet recruiting
- NCT06073314 — Novel Applications for Sarcoma Assessment · completed
- NCT05870098 — Meatal Swab Yourself With Testing for Infections Collectively · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06189131 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Leeds Teaching Hospitals NHS Trust
- Last refreshed: 19 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06189131.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing